Biologics effectiveness and safety (best) initiative #3: data sources for surveillance of biologics: "best 3"

Ended Awarded Last action

Contract number
75F40120D00026
Awardee
Awarding agency
Task orders
3 $44,375,230 obligated

Award facts

Combined order value
$44,375,230 Current and potential, with all options
Last date to order 100% complete
IDV ceiling 89% used
$50,000,000.00
Maximum order
$50,000,000.00
Award type
Multiple award
Who can order
Only the awarding agency
Set-aside
No set-aside
Competition
Full and Open Competition · 4 offers Negotiated Proposal / Quote
Pricing
Firm Fixed Price
Legislative mandates

Award details come from SAM.gov/FPDS.

About this IDV

The Department of Health and Human Services (HHS) Food and Drug Administration (FDA) awarded a multiple-award indefinite-delivery indefinite-quantity (IDIQ) contract for the Biologics Effectiveness and Safety (BEST) Initiative #3: Data Sources for Surveillance of Biologics. The prime contractor, The Lewin Group, Inc. (doing business as Lewing Group Inc.), a subsidiary of UnitedHealth Group Incorporated, will provide data sources containing administrative claims data or claims and electronic health record (EHR) data covering tens of millions of U.S. patients. The data must be longitudinal and allow for review of full medical charts to support the FDA's post-market surveillance of biologics. The $50 million IDIQ has a 5-year ordering period and does not include any set-asides. Subsequent delivery orders have been issued to The Lewin Group to perform work under this BEST Initiative #3 program, valued at $15.3 million, $25.7 million, and $5.1 million, with performance locations in Mosby, Virginia. This contract vehicle enables the FDA to efficiently access specialized data and analytics capabilities from the Lewin Group to enhance its biologics safety monitoring efforts.

Task orders

Transactions

Action Obligated Date
Other Administrative Action P00006 $0
Other Administrative Action P00005 · Add far clause 52.204-27 - biologics effectiveness and safety (best) initiative #3: data sources for surveillance of biologics: "best 3" $0
Other Administrative Action P00004 $0
Other Administrative Action P00003 $0
Other Administrative Action P00002 $0
Other Administrative Action P00001 $0
Original award $0

Quick answers

Who was awarded contract 75F40120D00026?

75F40120D00026 was awarded to The Lewin Group, Inc. by Food and Drug Administration (Department of Health and Human Services) on September 29, 2020.

How much is contract 75F40120D00026 worth?

Orders under 75F40120D00026 have obligated $44,375,230. 75F40120D00026's own ceiling is $50,000,000. A single order can be worth up to $50,000,000.

How many orders have been placed under contract 75F40120D00026?

3 orders have been placed under 75F40120D00026, the latest on September 30, 2023.

Who can order from contract 75F40120D00026?

75F40120D00026 is a multiple award indefinite delivery contract. Only the awarding agency can place orders on it.

Is contract 75F40120D00026 part of a contract vehicle?

Yes. 75F40120D00026 is part of BEST Initative - Data Sources For Surveillance of Biologics.

Was contract 75F40120D00026 competed?

The extent of competition for 75F40120D00026 was full and open competition. The government received 4 offers.

On GovTribe

See this IDV's full record

  • Every order and transaction
  • The awardee's other awards and teaming partners
  • Similar IDVs and recompete opportunities
  • Ask GovTribe AI about this IDV